Rhythm Pharmaceuticals
Product Manager, US Marketing
Commercial - Boston, MA - Full Time
Company Overview
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity Overview
Reporting to the Sr. Director, US Marketing, the Product Manager, US Marketing will be a key member of Rhythm’s US Marketing team. In this role, you will be responsible for developing and executing key programs and materials for both HCP and patient/caregiver audiences to support the commercial success of IMCIVREE for approved indications including POMC, PCSK1, and LEPR deficiencies and Bardet-Biedl syndrome. As our business model evolves, you will support disease education and future launch for programs in late-stage clinical development, such as Hypothalamic Obesity. You will partner with HCP and patient/caregiver marketing leads within the team and cross-functionally across Commercial, Regulatory, Medical and Field teams. If you are a detail-oriented self-starter and strategic thinker, able to effectively manage multiple projects at a time, and passionate about bringing therapeutic options to patients living with rare diseases, you will thrive in this opportunity.
Responsibilities and Duties
Qualifications and Skills
Our lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them.
We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity Overview
Reporting to the Sr. Director, US Marketing, the Product Manager, US Marketing will be a key member of Rhythm’s US Marketing team. In this role, you will be responsible for developing and executing key programs and materials for both HCP and patient/caregiver audiences to support the commercial success of IMCIVREE for approved indications including POMC, PCSK1, and LEPR deficiencies and Bardet-Biedl syndrome. As our business model evolves, you will support disease education and future launch for programs in late-stage clinical development, such as Hypothalamic Obesity. You will partner with HCP and patient/caregiver marketing leads within the team and cross-functionally across Commercial, Regulatory, Medical and Field teams. If you are a detail-oriented self-starter and strategic thinker, able to effectively manage multiple projects at a time, and passionate about bringing therapeutic options to patients living with rare diseases, you will thrive in this opportunity.
Responsibilities and Duties
- Partner with HCP and Patient/Caregiver Marketing leads on development, execution, and measurement of all disease education and branded programs and tactics
- Serve as Marketing lead for Legal, Medical, Regulatory review of all materials and programs
- Collaborate with agency partners on tracking of project status and budget for all deliverables
- Contribute to annual strategic brand planning process and other strategic initiatives throughout the year
- Partner with Field & Marketing Operations on management of print and fulfillment for all Marketing collateral
- Coordinate Marketing-led congress execution, including booth and symposia in partnership with HCP Marketing lead
- Liaise with Field & Marketing Operations to ensure successful management of logistics to support HCP speaker bureau
- Coordinate execution of Patient Ambassador Program in partnership with Patient/Caregiver Marketing lead
- Support team leadership on special projects as needed
- Travel approximately 20%
Qualifications and Skills
- Bachelor's degree preferred
- 5+ years of pharmaceutical marketing experience, or combination of education and experience
- Launch experience and rare disease experience highly preferred
- Understanding of pharmaceutical marketing and regulatory/compliance environment
- Ability to work collaboratively with cross functional stakeholders such as Regulatory, Medical, Legal, Market Research, Sales, Market Access
- Strong organizational and operational skills, with attention to detail and sound business judgment
- Strong critical thinking skills with a solution-oriented mindset
- Proven project management skills including objective setting, prioritization, planning, timeline and budget management, and pull-though of clear action plans
- Self-motivated, and highly energetic individual with the ability to adapt and thrive in a fast-paced and dynamic environment
- Willingness to take on additional responsibilities and contribute to the growth and success of the company
- Experience with Veeva Vault and PromoMats preferred
This role is based out of our corporate office in Boston, Massachusetts. Rhythm operates in a hybrid-work model. Candidates applying must be willing and able to be in the Boston office in coordination with their department and business needs. This role may involve some travel.
More about RhythmOur lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them.
We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.
